Changes are on the way for COVID vaccines after the FDA adjusted the standard of evidence needed to approve shots for the ...

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

Top officials for the Food and Drug Administration (FDA) laid out new requirements for yearly updates to COVID-19 shots, ...

The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending ...